Next-Generation Sequencing Stays Ahead of the Market Curve

The impact of genetic sequencing on life sciences research, biotechnology and medicine is unprecedented. In 25 years, genomic knowledge has been built on a staggering scale: first enabled with the innovation and commercialization of Sanger sequencing, pieced together in coordinated efforts between various institutes, and then tremendously accelerated with the introduction of higher-throughput next-generation sequencing (NGS) technologies.

Healthcare Reform Has Impact in Glucose Testing

Among the industries impacted by healthcare reform, we've predicted in our report on the ACA that IVD would fair better than pharma or non-testing medical devices.  Testing is by its nature preventative, and the theory was that more office visits from newly insured patients should lead to more.

Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Modern medicine’s more than century-long fight to treat cancer and eradicate tumors will likely benefit from a more diverse and effective arsenal in the coming years. Through a variety of routes and techniques, gene therapies are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor.

Broad-Based Growth Evident in Latin American IVD Market

Brazil figures heavily into IVD strategies for the Latin American continent with a population of over 200 million people and industry to support globally distributed supply operations. However, the country’s regional economic clout does not necessarily ensure its status as a leading target expansion market for IVD companies.

Are Prices for Veterinary Services Really Rising? A Recent VPI-Purdue Study and its Significance to the Veterinary Diagnostics Market

A recent insurer-sponsored study sought to define real pricing trends for services in the U.S. veterinarian industry. It found surprisingly that during the recession and afterwards (2009-2014) prices overall for canine veterinary services actually fell according to the generated index. Researchers found that the overall indexed drop in service prices was attributable to medical care services, which fell nearly 5% between 2009 and 2013. Wellness care services (25% of spending) including examinations, vaccinations and primary care tests, on the other hand, rose by roughly 8% in index price over the same period!


Subscribe to Kalorama Information Home RSS